Award-winning participants in the Department of Medicine’s second annual Research Day are studying diverse topics, including disease processes for atrial fibrillation; treatments for leukemia, diabetes and COPD; and the need for cortisol.
Ira Jacob Blader, PhD, associate professor of microbiology and immunology, will build on prior research to identify and explore a key host cell pathway essential for the growth of the infection-causing parasite Toxoplasma gondii.
University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).
With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.
With a focus on the Escherichia coli bacterium, Mark Sutton, PhD, associate professor of biochemistry, will build on a decade of research to further study the complex coordination of molecular mechanisms that contribute to mutations in DNA replication and repair.
A University at Buffalo study has revealed how Streptococcus pneumoniae—bacteria that harmlessly colonize the mucous linings of human throats and noses—become virulent when they travel to the middle ears, lungs or bloodstream.
Richard B. Bankert, VMD, PhD, professor in the Department of Microbiology and Immunology, and Zhen Yan, PhD, professor in the Department of Physiology and Biophysics, have received 2013 SUNY Chancellor’s Awards for Excellence.
Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.
UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.
Kate Rittenhouse-Olson, PhD, professor of biotechnical and clinical laboratory sciences, and Ernesto De Nardin, PhD, adjunct professor of microbiology and immunology, have co-authored a clinical immunology textbook.